Drupal-Biblio17<style face="normal" font="default" size="100%">HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study.</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Shared germline genomic variants in two patients with double primary gastrointestinal stromal tumours (GISTs).</style>Drupal-Biblio17<style face="normal" font="default" size="100%">A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin.</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Nivolumab and sunitinib combination in advanced soft tissue sarcomas: a multicenter, single-arm, phase Ib/II trial.</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial.</style>Drupal-Biblio17<style face="normal" font="default" size="100%">Pazopanib for treatment of advanced malignant and dedifferentiated solitary fibrous tumour: a multicentre, single-arm, phase 2 trial.</style>